Diana Papaioannou is an Assistant Director of the Clinical Trials Research Unit (CTRU) and a Senior Research Fellow with expertise in trial conduct and methodology and CTIMP trials (Clinical Trials of Investigational Medicinal Products).
Her areas of research are focused on clinical trial design, systematic reviews and adverse event recording in behavioural trials. It is the latter topic which we are going to explore as Diana has recently led a paper in The BMJ Research Methods and reporting titled ‘Recommendations on recording harms in randomised controlled trials of behaviour change interventions’.